Danish Pharmacovigilance Update, 17 March 2011

24 March 2011

In this issue of Danish Pharmacovigilance Update:

  • Reports of serious side effects in Japan from the childhood vaccines Prevenar (PCV7)® and Act-Hib®
  • Reports of serious side effects in France from the childhood vaccine Prevenar13®
  • Indication for Zerit® (stavudine) restricted due to potentially serious side effects
  • Rotarix and RotaTeq® and risk of intussusception
  • Tygacil® (tigecycline) and increased mortality in clinical studies
  • Thalidomide Celgene (thalidomide) and risk of myocardial infarction and thromboembolic events
  • New recommendations for use of Brinavess®
  • The Danish Medicines Agency has received a report of a death in connection with treatment with Concerta® (methylphenidate) for the treatment of ADHD
  • Antidepressants (SSRIs) and deaths or serious side effects in newborns
  • Consumption and side effects from the weight-loss product Regenon®

Download the newsletter in the factbox to the right.

Did you get answers to your questions?

Please tell us how we can improve our website? Please note that we do not answer questions asked via this feature.